This Week on NeurologyLive — April 19, 2021

April 19, 2021
NeurologyLive Staff

Here's what is coming soon to NeurologyLive.

Every week, the NeurologyLive staff prepares this preview of what to expect from our coverage. This week on NeurologyLive, there are a number of hot topics that we will be posting throughout the week. As always, our weekly coverage extends beyond just these topics, so make sure to check out the rest of the site!

All week, the NeurologyLive team is providing wall-to-wall coverage of the 2021 American Academy of Neurology Annual Meeting, which kicked off on Saturday, April 17. Our coverage features in-depth looks at the top data and presentations at this year's conference; interviews with key speakers, researchers, and clinicians; session recaps; and much more. Be sure to check back regularly for the latest. You can also follow along on Twitter with #AANAM.

To check out the latest AAN coverage, click here.

Today, the NeurologyLive Peer Exchange series, "Strategies in Treating Relapsing-Remitting Multiple Sclerosis," premieres! The series features a discussion on recommendations for appropriate treatment selection and use of high efficacy therapies as treatment for relapsing-remitting MS, and the panel includes Scott D. Newsome, DO, MSCS, FAAN; Patricia K. Coyle, MD; Robert Fox, MD; and Clyde E. Markowitz, MD.

To catch up on the series, click here.

Be sure to check out the MJH Life Sciences Medical World News channel this week, as a number of new shows featuring peers and colleagues in medicine will air! This week, on Wednesday, April 21, NeurologyLive will appear on the new show "Second Opinion." The show will feature migraine specialists Jessica Ailani, MD, director of the MedStar Georgetown Headache Center, and Deena Kuruvilla, MD, director of the Westport Headache Institute, who will share their experience and tips for handling both clinical and nonclinical scenarios.

To check out what's on the Medical World News channel now, click here.

The latest in our NeuroVoices series, dedicated to conversations with leaders in the neurology community, also goes live on Wednesday. This week's features Joseph Sirven, MD, professor of neurology, Mayo Clinic, who discussed his abstract from AAN 2021, on the role of social determinants in epilepsy treatment delays for Arizonans on Medicaid. With that, he detailed the reasons for gaps in diagnosis from the inpatient/emergency room setting compared to the non-traditional setting, as well as some of the most significant variables that correlated with treatment delays.

To check out the prior NeuroVoices conversations, click here.

The NeurologyLive Peer Exchange series, "Strategies for Managing Progressive Multiple Sclerosis During COVID-19," will premiere new episodes throughout this week. The series includes a panel of an expert neurologist, Mary Ann Picone, MD, as well as a patient with MS, and hosted by CMSC's own June Halper, MSN, MSCN, provides their perspectives on the overall management of progressive multiple sclerosis and the impact that the COVID-19 pandemic has had on these processes.

To catch up on the series, click here.

On Friday, April 23, episode 34 of the NeurologyLive "Mind Moments" podcast will go live. This iteration will feature an exclusive conversation with Daniel Claassen, MD, MS, associate professor of neurology, and division chief, Behavioral and Cognitive Neurology, Vanderbilt University Medical Center, about the current state of care in Huntington disease, particularly in light of the recent news of Roche and Wave Life Sciences halting development programs of agents for the disease.

To subscribe on your favorite podcast player, click here.

This week, new episodes of the NeurologyLive Peer Exchange series, "The Changing Landscape in the Treatment of Spinal Muscular Atrophy," go live. The series features Crystal Proud, MD; Claudia Chiriboga, MD, MPH; Tom Crawford, MD; Basil Darras, MD; and Carolina Tesi Rocha, MD, who discuss the importance of early diagnosis and treatment of spinal muscular atrophy and consider data from recent clinical trials of disease-modifying therapy options.

To catch up on the series, click here.